Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' ...
Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...